Melanoma Nursing Webinar Program
Delivering personalised, supportive care in melanoma
This webinar was delivered on the15 January 2026, 1-2 pm
This webinar focused on delivering personalised/ supportive cancer care in melanoma centring on quality of life in patients with stage III/IV melanoma.
Nurses will gain insights into why it is important to consider the impact of treatment on quality of life in different treatment settings for melanoma, exploring how models of care can be changed to better address quality of life issues for individual patients. The session will provide an overview of health-related quality of life and explore how the impacts of different treatments may affect patients in different ways, highlighting the melanoma specialist nurse’s role in personalised/ supportive cancer care in Melanoma and empowering nurses with the necessary knowledge to support melanoma patients through different treatments.
Learning outcomes:
- Understand why it is important to consider the impact of different treatments for melanoma on quality of life
- Identify how health-related quality of life can be impacted by different treatments
- Understand how models of care can be used to personalise cancer care in Melanoma
- Enhance the specialist melanoma nurse’s role in assessing and addressing unmet needs to facilitate personalised/ supportive cancer care
Audience: MIA program nurses - live event. Recording to be available to a larger nursing cohort.
Speakers
 |
Dr Julia Lai Kwon Dr Julia Lai-Kwon is a Medical Oncologist and Health Services Researcher at Peter MacCallum Cancer Centre, Melbourne, Australia. She has previously trained at the Royal Marsden Hospital, United Kingdom, and the Melanoma Institute Australia in Sydney, Australia. Her clinical interests are melanoma and other cutaneous malignancies. Dr Lai-Kwon has research expertise in quality of life research, survivorship and patient-reported outcomes. She has presented nationally and internationally and published on the survivorship experience of people with metastatic cancers receiving immunotherapy and targeted therapy, quality of life issues in people with metastatic melanoma, and the use of patient-reported outcomes in clinical trials and routine care. She has completed a PhD under the supervision of Prof Michael Jefford, A/Prof Claudia Rutherford and A/Prof Stephanie Best on the co-design of a remote symptom monitoring for people receiving immune checkpoint inhibitors. Dr Lai-Kwon is an active member of the EORTC Quality Life Group, the International Society for Quality of Life Research (ISOQOL), and the Multinational Association for Supportive Care in Cancer (MASCC). |
|
Chair: Kathe Holmes
|
Resource details
This course is brought to you by
